The onset of embryonic malformations is greatly determined by the intrauterine environment, conditioned by maternal lifestyle, diet, drugs and medication intake, in addition to both foetal and maternal genotypes. Maternal C677T MTHFR genotype has been identified as important factor in cleft lip with or without e1eft palate (CLIP) etiology. In the present study we evaluated the possible interaction between maternal methylenetetrahydrofolate reductase (MTHFR) and foetal ABCBI genotypes. ABCBI gene codes for a drug-transport pump in charge to protect the cell by extruding a variety of harmful exogens, but with a reduced activity in a folate-restricted condition. Maternal 677T genotype is translated in a reduced folate availability for the developing embryo who consequently may becomes more exposed to external insults. A family based association analysis was performed to test the effect of ABCBI polymorphisms in clefting, in the whole sample and in the stratified sample accordingly to maternal MTHFR genotype. No evidence of association between ABCBI polymorphisms and CLIP was detected. This suggests thatABCBI or ABCBI-MTHFR feto-maternal interaction could have no effect in orofacial cleftlng or could playa role in a limited number of cases.
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Nonsyndromic cleft lip with or without cleft palate (CLIP) is the most common craniofacial malformation. This congenital pathology presents a complex aetiology, in which act both genetic and environmental factors. In this context, embryo's development depends on its genetic factors and on uterine environment. In addition, this microcosm can be conditioned by mother's genetics and hexogen causes. In order to clarify CLIP aetiology, it is important to investigate how maternal or foetal genetic susceptibility factors interact with environmental causes.
Since the first evidence for a possible involvement of a environmental component in clefting (1), number of studies have been carried out to discriminate clefting teratogens. Among medications during periconceptional period, anti-epileptic drugs were shown to be associated with oral clefts, as demonstrated for sodium valproate (2) and for nitrofurantoins (3) . Moreover, assumption of corticosteroids has been associated to a moderately higher CLIP risk (4) .
It is a current opinion that periconceptional health status and maternal lifestyle factors could influence the occurrence of CLIP malformation. In particular, periconceptional folate intake with food (5) and folic acid supplementation (6) have been seen to reduce the risk for CLIP in the offspring. Folate is essential to maintain DNA stability, by acting in DNA synthesis, repair, and methylation. A key enzyme in the folate pathway is the methylenetetrahydrofolate reductase (MTHFR). The common MTHFR 677T variant is translated in a reduced folate availability in mother and then for the embryo, who uses maternal reserves. The maternal MTHFR genotype has been seen associated to increased risk of CLIP by our group (7) .
Moreover, maternal smoking combined with maternal glutathione s-transferase q-l (GSTTl) genotype, seems significantly to increase the risk of CLIP (8) . The same environmental factor contributes to exacerbate the risk for CLIP (7.16 times) in combination with MSXl specific genotypes in foetus (9) . Thus, experimental evidences supporting that specific exposures can synergistically act with genetic predisposition on clefting risk have been collected.
Several drugs, potentially harmful for the cell are eliminated through the plasma membrane by the P-glycoprotein (P-gp), coded by the ABCB I (old nomenclature MDRl) gene. In addition to drugs, such as antiretrovirals and immunomodulators, ABCB 1 substrates include a wide variety of physiological lipophilic molecules like phospholipids. Thus, ABCB 1 could be a part of the cell defense system against dangerous pollutants. In 1998 Lankas and colleagues (10) demonstrated that P-gp deficient (-J-) mice embryos were 100% susceptible to chemically induced cleft palate. Based on the fact that several medications are substrates for the P-gp, Bliek and colleagues investigated the ABCBl 3435C>T polymorphism, to verify whether it could modulate CLIP risk due to periconceptional drug assumption (11). The authors found a 6.2-fold increase of CLIP risk for maternal ABCBl 3435TT genotype in combination with periconceptional medication use. Besides, the increment was 30% lower ifmothers assumed medication jointly to folic acid.
In the present study, a family based association study was undertaken to verify the involvement of ABCB 1 polymorphisms in CLIP aetiology, including a possible foetus-maternal genetic interaction between ABCB I and MTHFR.
MATERIALS AND METHODS

Study population
For this investigation, we enrolled 403 unrelated probands with nonsyndromic CLIP and their parents. Genomic DNA was available from 399 patients, 397 proband's mothers, and 386 proband's fathers. Among patients, 292 cases are considered sporadic or non-familial, as no other relative shares the same malformation, while III cases have a positive familial history. With the aim to work in a homogeneous population context, probandswho did not demonstratea certainItalian ancestrywere excluded from the sample study. To assess nonsyndromic CLIP status and periconceptionalbehaviour,patients and their parents were interviewed in deepened way regarding family history. In order to discriminate among known teratogenic influences, motherswho assumedcleftingdrugs such as phenitoin,warfarin, and ethanol were excluded from the study.The CLIP status was diagnosed as sole clinical feature by maxillofacial clinicians. After informed consent, peripheral venous blood samples were drawn from all participating family members and DNA extraction was performed,as previously described (12) .
Markers
For the ABCB1 examination,three common polymorphisms were typed by restrictionanalysis: C1236T (rs1128503) located in the exon 12, G2677T/A (rs2032582) of the exon 21, and C3435T (rsI045642), mapping in the exon 26, respectively. PCR products of 340 (CI236T), 298 (G2677T/A), and 220bp (C3435T) were digested with HaeIII, Gsa! and DpnI respectively, and the so obtained fragments visualised in 2% high resolutionagarose gel in the presence of ethidiumbromide. Even C677T MTHFR maternal genotype was assessed by restrictionanalysis on amplimers as previously described (13) .
Statistical analysis
The distribution of genotypes among both proband and parent groups was tested for deviation from the Hardy-Weinberg equilibrium using Pearson's X2 test. The Haploview program was used to examine linkage disequilibrium between markers (14) .Allelic associationwas conductedwith the familybased association tests implemented in the FBAT program v2.0.3 (15) . The additive genetic model was applied for each allelic association test, which examines the transmission of the marker alleles from parents to the affected offspring. The haplotype version of FBAT (HBAT) was applied to test the associationbetween phenotype and haplotypes (16) . The "mode a" command was used to obtain both biallelic and multiallelic tests.
A log-linear method for the analysis of case-parents triad data,basedon maximumlikelihoodwithstratification onparental mating types, was used to test different genetic hypotheses. The log-linear model was used to test whether maternal genotypes at ABCB I locus could influence the risk to deliver a CLIP affected child (17) . The method was implemented using LEM free software (18) using specific scripts made available by the Weinberg group (http://www.niehs.nih.gov/researchlatniehs/labs/bb/staff/ weinberg/docslLEM_scripts.zip). Likelihood-ratio tests (LRT) for maternal association was compared to the chi-squared reference distributionwith two degrees-of-freedom.
Statistical calculations were repeated on data that were stratified accordingly to mother genotype at rs1801133, i.e. the commonlyknown as MTHFR C677T polymorphism.
RESULTS
A family based association study was conducted with three nonsynonimous SNPs at ABCB 1 locus. Genomic DNA from 1182 individuals was typed with a call rate higher than 99%. Genotype distributions among probands and their parents did not significantly differ from those expected by the Hardy-Weinberg equilibrium (Table I) . Two different methods were adopted to test whether particular alleles or genotypes could influence the risk of CLIP. Firstly, a conventional family-based association study was performed to test ABCB 1 involvement in clefting. Specifically, the association tests implemented in FBAT and HBAT program were performed to verify whether a specific patient's allele or haplotype may influence the risk of CLIP. Single marker analysis rejected the association hypothesis with each ofthe markers (Table  II) , while a borderline P value of0.06 was obtained for the global haplotype association test. No alteration of single haplotype transmission was observed.
In addition to the standard association analysis, a loglinear, likelihood-basedmethod was used to test whether the maternal genotype could influenceCLIP risk. The likelihood ratio test ofMother effect versus Null provided no significant deviation for each tested polymorphism (Table II) .
Since we previously observed a significant association between the maternal MTHFR C677T genotype and risk to deliver a CLIP affected child, association analyses were performed also with the sample stratified in three different triad groups, that were identified basing on the maternal MTHFR genotype (Tables I). No evidence of association between CLIP and child or mother genotypes was obtained (Table II) .
DISCUSSION
The embryo development is conditioned .by different factors. Obviously, by embryonic genetics. Not to be underrated, the intrauterine environment, that could be influenced by maternal health status, lifestyle, drug assumption, diet, vitamins supplementation, genetic factors, exposure to environmental teratogens. The appraisal of the consequences of different combinations of maternal/embryo genetic condition and environmental factors seems to be the next goal for geneticists engaged in the study of malformation aetiology.
Our group previously collected evidences supporting that maternal genotypes at the MTHFR gene can influence the risk ofoffspring affected by CLIP, probably modulating folate availability for the embryo (7) . The hypothesis of the present study was based on the fact that the ABCB 1 studied polymorphisms, although being catalogued as synonymous mutations, seemed to be associated with an increased degradation of the ABCB 1 mRNA and consequently a decreased P-gp expression (19) . A lower P-gp expression could result in a reduced defense for the fetus against hexogens. This situation could being exacerbated in case of maternal 677T allele for MTHFR gene that is translated in a reduced availability of folate for the embryo. In addition evidences about a role of multidrug resistance proteins (MRPs) in cellular folate export have been reported (20) . In fact, as suggested by Hooijberg and colleagues (21) , the cell in a folate-restricted condition limits the extrusion activity of MRPs in order to retain cellular folates. The side effect of the diminished activity of these transporters is a reduction of cell protection against xenotoxins. Since ABCB 1 belongs to MRP family, this situation seems a possible scenario for children of mothers carrying the T allele at C677T MTHFR.
In the present investigation we tested whether foetal ABCB 1 genotype can alter the risk of clefting and whether this can be further influenced by a combination with specific maternal MTHFR genotypes that determine a folate depleted uterine environment. The family based association study provided no evidence of association between ABCa 1 polymorphisms and clefting. Lack of association could mean that the tested hypothesis was not true, but it could also mean that the sample size was not sufficient to detect a very low effect. Being unfeasible to evaluate mother exposure to unrecognized pollutants, a possible effect of ABCB 1 variants could be masquerade by a low level of exposure in our sample. A sample selection criteria including periconceptional drugs or medication assumption may help to increase the power of the study, thus identifying the possible foetus-maternal interaction between ABCB 1 and MTHFR genotypes.
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